We want to highlight the fruitful collaborations in the cluster. In a new article series, we present members who have a cluster story to tell. This week, we meet LINK Medical.
Author Archive for: oslocancer
This author has yet to write their bio.Meanwhile lets just say that we are proud oslocancer contributed a whooping 515 entries.
Entries by oslocancer
Novartis joins the IMPRESS oncology study with six of its cancer medicines to treat up to one hundred patients.
Five new partners have joined CONNECT.
Eva S. Dugstad is our new research and industry facilitator aka competence broker for Oslo-based companies.
Contact us >
Oslo Cancer Cluster Innovation Park opened in May 2015.
The Innovation Park brings together the oncology-value chain from basic research to industry within the Oslo-area.
Our vision is to create Europe's leading environment for education, research and industry within oncology, shortening the development time of new cancer treatments.